Exosomes in the Thymus: Antigen Transfer and Vesicles by Gabriel Skogberg et al.
MINI REVIEW




University of São Paulo, Brazil
Reviewed by:
Bin Li,
Chinese Academy of Sciences, China
Nuno L. Alves,
University of Porto, Portugal
*Correspondence:
Gabriel Skogberg,
Department of Rheumatology and
Inflammation Research, Sahlgrenska
Academy, University of Gothenburg,
Guldhedsgatan 10A, Gothenburg
Västra Götaland, Gothenburg
SE 405 30, Sweden
xskoga@gu.se
Specialty section:
This article was submitted to
Immunological Tolerance, a section of
the journal Frontiers in Immunology
Received: 14 May 2015
Accepted: 06 July 2015
Published: 20 July 2015
Citation:
Skogberg G, Telemo E and Ekwall O
(2015) Exosomes in the thymus:
antigen transfer and vesicles.
Front. Immunol. 6:366.
doi: 10.3389/fimmu.2015.00366
Exosomes in the thymus: antigen
transfer and vesicles
Gabriel Skogberg1*, Esbjörn Telemo1 and Olov Ekwall1,2
1 Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, Gothenburg
University, Gothenburg, Sweden, 2 Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy,
Gothenburg University, Gothenburg, Sweden
Thymocytes go through several steps of maturation and selection in the thymus in
order to form a functional pool of effector T-cells and regulatory T-cells in the periphery.
Close interactions between thymocytes, thymic epithelial cells, and dendritic cells are of
vital importance for the maturation, selection, and lineage decision of the thymocytes.
One important question that is still unanswered is how a relatively small epithelial cell
population can present a vast array of self-antigens to the manifold larger population
of developing thymocytes in this selection process. Here, we review and discuss the
literature concerning antigen transfer from epithelial cells with a focus on exosomes.
Exosomes are nano-sized vesicles released from a cell into the extracellular space. These
vesicles can carry proteins, microRNAs, and mRNAs between cells and are thus able to
participate in intercellular communication. Exosomes have been shown to be produced by
thymic epithelial cells and to carry tissue-restricted antigens and MHC molecules, which
may enable them to participate in the thymocyte selection process.
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Introduction
Exosomes are small (30–100 nm) vesicles released by cells into the extracellular space. They are
a subgroup of extracellular vesicles (EVs) formed by inward budding of membranes in the late
endosomes, thus creating a multi-vesicular body (MVB), which may dock to the outer membrane
of the cell and release its content of exosomes (1, 2). In hindsight, the recycling of the transferrin
receptor back to the cell membrane from an endocytic route in developing erythrocytes was the
original description of exosomes in 1983 (3). One particularly striking finding, which in recent years
has heavily influenced exosome research, was the identification of microRNA (miRNA) and mRNA
in exosomes (4). Exosomal transfer of functional miRNA and mRNA has been demonstrated to
result in regulation of gene expression through miRNA as well as translation of proteins through
mRNA in recipient cells (5, 6). Exosomes are abundant in, and fairly easy to purify from, bodily
fluids such as saliva (7), peripheral blood (8), bronco alveolar lavage fluid (9), and urine (10, 11), and
one area of extensive research is the use of exosomes as diagnostic biomarkers for various pathologic
conditions (12).
Exosomes have also shown therapeutic promise, e.g., in a study by Zitvogel and co-workers it was
demonstrated that tumor peptide-pulsed dendritic cells (DCs) released exosomes that carriedMHC
I and II as well as co-stimulatory molecules and that these exosomes primed cytotoxic T-cells and
suppressed the growth of established tumors (13). Native antigens on tumor-derived exosomes can
be taken up by DCs and cross-presented to tumor-specific cytotoxic T-cells (14).
Other studies have revealed that exosomes are capable of presenting antigens to T-cells. In 1996,
Raposo et al. (15) reported that both human and murine B-cell derived exosomes could induce an
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antigen-specific MHC II-restricted T-cell response. Exosome-like
structures, named tolerosomes, are released from epithelial cells
of the small intestine and have been shown to induce specific
tolerance to fed antigens (16). As with the B-cell derived exo-
somes, tolerosomes seem to deliver antigens in aMHC dependent
manner (17).
The thymus is the organ responsible for the establishment of
an immune competent but yet self-tolerant T-cell population.
While the extreme diversity of the mature effector T-cell speci-
ficities is a prerequisite for an effective defense against invading
pathogens/infectious agents, the negative selection of self-reactive
effector T-cells and the positive selection of T regulatory cells
ensure tolerance to self-structures in order to avoid autoimmu-
nity. To ensure a self-tolerant peripheral population, thymocytes
are selected against a comprehensive set of self-antigens (18) of
which many are produced and presented by medullary thymic
epithelial cells (mTECs) (19) under control of the autoimmune
regulator (AIRE) (20). The importance of a functional thymic
antigen expression has been validated in models where even a
defect expression of a single antigen may lead to development
of peripheral organ-specific autoimmunity (21). Of equal impor-
tance is the selection of regulatory T-cells (Tregs) within the
thymus, foremost from clones with a somewhat elevated TCR
avidity for self-antigens (22). Proper thymic Treg development
is also dependent on AIRE, and in particular for the func-
tionally important Tregs that are induced during the perinatal
period (23).
Since thymocytes outnumber TECs by several orders of mag-
nitude, and the fact that each individual TEC only expresses a
small subgroup of self-antigens (18, 24), a possible dissemination
of antigen fromTECs has been discussed in order to aid individual
TECs to cover an extended volume of the thymic microenvi-
ronment (25). This would increase the number of possible anti-
gen–thymocyte interactions and allow additional impact of the
thymic DC populations. Antigen transfer could potentially occur
by different means such as apoptotic bodies, nanotubes, and/or
exosomes. Here, we review the current literature and argue that
thymic exosomes have a potential role in T-cell maturation and
selection.
Antigen Transfer and Indirect Antigen
Presentation in the Thymus
Clearly, direct cell–cell contacts in the thymus are pivotal for the
development of a functional T-cell population (26). The addition
of antigen transfer between thymic cell populations could, how-
ever, optimize thymic cell communication by making antigens
more available to the pool of developing thymocytes. Through
the last two decades, a number of studies performed under dif-
ferent experimental conditions have demonstrated the transfer
of antigens from TECs to DCs. Already in 1994, Kyewski and
co-workers observed intercellular transfer of Eα52–68 (a-chain of
the MHC class II allele I-Ed, amino acids 52–68) from TECs to
thymic DCs in a unidirectional fashion (27). They proposed that
this mechanism “may enhance the efficacy of tolerance induction
by spreading self-antigens” (27). Subsequent experiments with
OVA-specific TCR-transgenic mice (RIP-mOVA model) revealed
that transfer of antigen to and presentation by hematopoietic cells
also applies to MHC class I-restricted epitopes, since it resulted in
deletion of both MHC class I- and MHC class II-restricted OVA-
specific thymocytes when OVA was expressed only by mTECs
(28). The identity of the hematopoietic cells in the RIP-mOVA
studywas unclear but further studies have revealed that deletion of
CD11c+ cells using CD11c-Cre mice crossed with mice express-
ing diphtheria toxin under the control Rosa Locus containing
a loxP-flanked STOP cassette results in increased frequencies
of CD4+ thymocytes and increased CD4 T-cell infiltration into
peripheral tissues (29). Likewise, Aschenbrenner and colleagues
have observed that DCs capture mTEC-derived antigens and take
part in deletional tolerance (30). This observation was strength-
ened by a study by Koble and Kyewski who demonstrated a
presentation of TEC antigens by DCs. In their study, thymic but
not peripheral DCs presented TEC-derived OVA to OVA-specific
T-cells and were constitutively provided with mTEC-derived pro-
teins (31). Further, unidirectional antigen transfer from mTEC
to DCs was shown to also apply for native endogenous self-
antigens in vivo (31). Non-redundant contribution of DCs and
mTECs is further suggested based on simultaneous hematopoietic
MHC class II deficiency and reduced MHC II expression on
mTECs; this combination has an additive worsening effect on
negative selection compared to either of the single deficiencies
alone (32).
Also, the Treg formation seem to be dependent of DC-TEC
cross-talk, which was elegantly demonstrated in a study on bone
marrow chimeras in which CD28/B7 signaling was disrupted
on either hematopoietic-derived antigen-presenting cells (APCs)
or on TECs. The results showed that when B7 was restored
in the hematopoietic-derived APCs this was enough to restore
Treg numbers, hence hematopoietic-derived APCs and TECs can
independently contribute to Treg development (33). The transfer
of material in this study was unidirectional toward DCs, and
the discussed mechanisms were primarily exosomes and apop-
totic bodies. Transfer of material from TECs to DCs has also
been demonstrated in the work by Hubert and co-workers in
which OT-II restricted thymocytes were deleted by a soluble
form of OVA that required presentation by bone marrow-derived
cells (34). Using tetramer staining and transfer of bone marrow
with ablated expression of MHC II, Taniguchi and co-workers
found an abolished negative selection of T-cells specific for the
AIRE-controlled self-antigen retinoid-binding protein (35). They
concluded that intercellular transfer of the interphotoreceptor
retinoid-binding protein peptide epitope of amino acids 277–290
from AIRE-expressing mTECs to bone marrow-derived APCs is
important for negative selection of the investigated peptide. In re-
aggregated thymic organ cultures, both the thymic epithelium and
conventional DCs (as opposed to plasmacytoid DCs) have been
shown capable of eliminating autoreactive CD4 thymocytes and
to support natural Treg (nTreg) development on their own (36).
In addition, Perry and co-workers recently reported that CD8 α+
DCs preferentially acquire and present AIRE-dependent antigens
to developing Treg cells (37). They also showed that bonemarrow-
derived APCs and mTECs play non-overlapping roles in shaping
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of the T-cell receptor repertoire in terms of deletion and Treg
selection (37).
T-Cell Stimulation by Exosomes, With
or Without DCs
The capacity of exosomes to directly stimulate target cells has been
debated. Some studies have suggested that there is an absolute
need for DC presence for efficient exosomal stimulation of T-
cells (38–40), while others have shown that exosomes are able
to directly stimulate T-cells without any aid from DCs (15, 41–
44). Models in which the efficiency of exosomal T-cell stim-
ulation increases by DC presence have also been put forward
(45). Interestingly, thymic exosomes carry ICAM-1 (46), which
is both required for efficient T-cell responses (40) and involved
in exosome binding to DCs (47). In addition to ICAM-1, thymus
exosomes carry the opsonin MFGE8, which indicates that thymic
exosomes would readily be engulfed by APCs such as DCs (46).
TEC exosomes are also strongly positive for HLA-DR, which
suggest a possibility that they contribute with antigens not only
indirectly via, e.g., DCs but also directly to developing thymo-
cytes (48). The presence of co-stimulatorymolecules on exosomes
may be important for their potential to affect the maturation
of nTreg precursors (49). However, whether TEC exosomes that
carry antigen presentation molecules and antigens need APCs or
not to participate in thymocyte selection in vivo is not known.
Possibly, thymic exosomes could take part in negative selection
both directly by interacting with the thymocytes or indirectly by
delivering antigens to APCs such as thymic DCs (Figures 1A,B).
Characteristics of Thymic Exosomes
The first observation of exosome-like structures in thymic tissue
was made by Wang and co-workers (50). These mouse thymic
exosomes were characterized by high content of TGF-beta, CD9,
and MHC II. In human beings, thymic exosomes were originally
characterized with the use of explant cultures (46). The thymic
exosomes shared features with exosomes from other sources, such
as a size distribution of 30–100 nm for a majority of the vesicles,
density peaking at 1.18–1.19 g/ml, which is less than the typical
density of histone dense apoptotic bodies (51), and presence of
typical exosomal proteins such as TSG101, CD9, CD81, andHLA-
DR. Since these thymic exosomeswere isolated fromwhole thymic
tissue, the cellular source could not be determined, and the vesicles
weremost probably amix of exosomes fromdifferent sources, e.g.,
thymocytes, TECs, and DCs. Even so, tissue-restricted antigens
(TRAs), defined by protein-expression allowed in a maximum of
five tissues in the human protein atlas (HPA) (52) were identi-
fied in the exosomes (20,30-cyclic-nucleotide 30phosphodiesterase,
reticulon 3, tropomyosin 3, and the GNAS protein), which suggest
that a portion of the exosomes originates from the thymic epithe-
lium (46). These four identified TRAs are possible candidates
to participate in the selection/maturation processes within the
human thymus. With the exception of one study that address
thymic expression of 20,30-cyclic-nucleotide 30phosphodiesterase
(53), the four TRAs are hitherto unaddressed in thymic research.
Interestingly, 20, 30-cyclic-nucleotide 30phosphodiesterase is rec-
ognized by IgG autoantibodies in multiple sclerosis patients (54).
In addition, tropomyosin 3 was suggested to be a candidate
antigen in endometriosis (55).
Other traits seem to be specific for thymic exosomes compared
to exosomes from other sources. One is the massive yield of
~1mg of thymic exosomes per gram of thymic tissue grown in
an explant culture (46). Other characteristics typical for thymic
exosomes are the low expression of CD63 and the high expression
of TSG101 on their surface (46). However, low levels of CD63
could have functional implications for thymic exosomes since
it has been reported that siRNA mediated knockdown of the
tetraspanin CD63 in a B-lymphoblastoid cell line (LCL) resulted
in an increased CD4+ T-cell recognition as evaluated by IFN-γ
production. The increase inT-cell response could not be explained
by changes in antigen processing or MHC II-expression (56).
Instead, equal amounts of exosomes from CD63low LCL cells and
control LCL cells stimulated the T-cells to comparable degrees, but
the CD63low LCL cells producedmore exosomes, which in the end
enhanced the total T-cell-stimulatory capacity of the CD63low LCL
cells.
Formal proof that TECs are able to produce exosomes was
provided with the use of an approach in which primary cultures of
TECs were established under selective conditions to eliminate the
presence of thymocytes, DCs, fibroblasts, and peripherally pro-
duced exosomes (48, 57). The results showed that TECs produce
exosomes and that these exosomes contained TRAs and a number
of known autoantigens (48). Among the identified autoantigens
in TEC exosomes were myelin basic protein (58), collagen type II
(59), TITIN (60), heat shock protein 60 [connected with various
autoimmune diseases (61)], transglutaminase 2 (62), desmoglein
1, and desmoglein 3 (63). In addition to autoantigens, previ-
ously reported mTEC-enriched TRAs were present in TEC exo-
somes, e.g., glutathione S-transferaseM3 (GSTM3), LDL receptor,
monocarboxylate transporter 4 (SLC16A3), mucins (MUC5B and
MUC18), and myosin 1B (MYO1B) (48).
The observation that TEC exosomes have a higher fraction
of proteins classified as TRAs (24%) compared to the fraction
of TRAs in the cultured TECs (21%) could argue for a directed
loading of TRAs into the exosomes (48).
Exosomes isolated directly from thymic tissue and exosomes
isolated from TEC-cultures share a set of TRAs, such as 20,30-
cyclic-nucleotide 30 phosphodiesterase, which strengthens that
thymic explant exosomes are partly of epithelial origin and that
their TRA-content can be analyzed with whole thymic tissue as
starting material. See Figure 1C for a schematic summary of the
TEC-exosomal proteome. In addition, the presence of antigen-
presenting molecules together with TRAs indicates that exosomes
could transfer intact functional peptide-MHC complexes.
RNA Transfer by Exosomes
Exosomes have been increasingly recognized for their ability to
transfer functional miRNAs and mRNAs between cells (4), and
recently, it was shown that Tregs utilize exosomes for transfer of
miRNA in order to functionally silence effector T-cells (64). The
importance of miRNAs in the thymus has rendered an increased
interest, andmiRNAshave been shown to affect promiscuous gene
expression under the influence of AIRE (65, 66), to be involved in
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FIGURE 1 |Models for transfer of exosomal material from TECs to other
thymic cell populations. Transcription and translation of AIRE-dependent
TRAs followed by TRA loading of exosomes, MVB fusion with the mTEC plasma
membrane leading to exosome release from mTECs. The exosomes could then
take an intercellular route from mTECs directly (A) to CD4+, CD8+, and
developing nTregs and/or indirectly (B) via thymic DC or other APCs. (C) The
proteome of thymic exosomes typically include exosomal markers, e.g.,
tetraspanins, TEC associated proteins, TRAs, and autoantigens (46, 48).
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FIGURE 2 | (A) Thymic exosomes contain miRNAs that could be taken up by
adjacent cells. (B) Suggested model describing two principally different routes
for TRA loading onto exosomes. TRAs could be engulfed by phagophores,
which are processed to autophagosomes that fuse with MVBs where TRA
carrying exosomes are formed. Alternatively, TRAs are directly directed into
MVBs.
thymic involution (67) and the maintenance of thymic epithelia
(68). Thymic exosomes contain a number of miRNAs, and among
them is the highly TEC enriched miRNA hsa-miR-149 (66). The
role of thymic miRNAs has been thoroughly reviewed recently
(69). Possible roles for miRNA sharing within the thymus by
exosomes include control of TEC development and regulation of
TRA expression. See Figure 2A for a schematic view of miRNA
incorporation into TEC exosomes.
Exosomal Biogenesis – Crossroads with
Autophagy?
Autophagy may serve as a way to generate self-peptides from
endogenously produced proteins that allows loading ontoMHCII,
and the constitutive autophagy process present in the thymus
has been suggested to be involved in the negative selection and
Treg formation (70). Thymic exosomes carry proteins involved
in autophagy, such as autophagy related protein 7 (46). Two
interesting observations are that a subgroup of TECs is rich
in MVBs (71), and that at the same time, TECs have a con-
stitutive autophagic activity (72). The simultaneous appearance
of autophagic ultrastructure elements and multi-vesicular bod-
ies in TECs support this notion (71). The intersection between
autophagy and exosome formation is illustrated by the regulation
of both autophagy and exosome biogenesis by GAIP interacting
protein C terminus in pancreatic cancer cell lines (73). Exosomal
release is also impaired in mouse embryonic fibroblasts lacking
ATG12-ATG3, and immature autophagosomes are shown to fuse
with MVBs in these cells (74). Whether this also occurs in TECs
is so far unaddressed, but this route could potentially make anti-
gens that are processed in the autophagic machinery available for
export on exosomes and at the same time enhance the loading of
endogenous antigens onto MHC class II molecules (Figure 2B).
Concluding Remarks
Tissue-restricted antigen presentation within the thymic
micromileus is pivotal to establish central tolerance. Antigen
transfer between thymic cell populations, e.g., from mTECs to
thymocytes and DCs is an established phenomenon that is poorly
investigated from a mechanistic point of view. To get a more
comprehensive understanding of central tolerance, the role of
antigen transfer and the responsible vectors, e.g., exosomes, need
to be studied and understood in more depth.
The abundant presence of TRA-containing exosomes in thymic
tissue and the many observations of antigen transfer frommTECs
to DCs lead us to speculate that this antigen transfer is, at least
partly, mediated by exosomes. However, such a mechanism has
not yet been formally proven. Although this review has been
focused on possible antigen transfer by mTEC-derived exosomes
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to DCs and thymocytes, it is not excluded that also cTECs pro-
duce exosomes and that exosomes are shuttling antigens between
different TEC populations. Other questions also remain regarding
thymic exosomes that are equally important to answer in future
studies; do exosomes exist in vivo in enough quantities to be
biologically functional in the context of tolerance induction? If so,
which is the primary route, direct interaction with thymocytes or
indirect via APCs? What is the importance of exosomes for nTreg
induction? Also, does miRNA content of the exosomes affect the
development and maturation of thymic cells? Examples of exper-
imental approaches that could be used to address these questions
are TEC specific inhibition of the ESCRT machinery using the
FOXN1-cre system ormicroinjection of thymic exosomes isolated
from wild type mice into AIRE /  thymii. The outcome of this
kind of experiments may give hints to whether a therapeutic use
of tailor made exosomes to induce antigen-specific tolerance may
be possible in the future.
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